Procurement of one (1) Brand Name or Equal Illumina NextSeq 550 Dx Sequencing System
Closed Solicitation Posted
- Solicitation number
- RFQ-75N91024Q00086
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services (DHHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Laboratory of Pathology (LP), Comprehensive Oncologic Molecular Pathology and Sequencing Service (NCI-COMPASS) seeks to procure one (1) new, commercially available, clinical-grade benchtop In-Vitro Diagnostic (IVD) instrument, specifically the Illumina NextSeq 550 Dx Sequencing System or an equal. This requirement will be awarded as a firm fixed price purchase order under FAR Part 13 - Simplified Acquisition Procedures. Quotes are due by 4:00 PM EST on June 10, 2024, and the Government intends to evaluate quotes and make a single award to the offeror that submits the Lowest Price Technically Acceptable quote. The NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing) with a size standard of 1,000 employees.
This solicitation is not set aside for any specific business type. The place of performance is Bethesda, MD 20892, USA. There is no mention of any incumbent contractors or the potential award value. The requirement is for one (1) sequencing instrument that meets the specified technical capabilities, including a sequencing output of >90 Gb and proven Sequencing by Synthesis (SBS) chemistry. The successful offeror must also accept a trade-in of one existing Ion S5 XL Sequencer and provide a 12-month warranty on all equipment. Delivery is required within four weeks of award, with installation to be completed within 14 calendar days of delivery.
Notice text
***Please read the attached documents***
The Department of Health and Human Services (DHHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Laboratory of Pathology (LP), Comprehensive Oncologic Molecular Pathology and Sequencing Service (NCI-COMPASS) requires one (1) new, commercially available, clinical-grade benchtop In-Vitro Diagnostic (IVD) instrument.
This is a combined synopsis/solicitation for commercial items, prepared in accordance with format in FAR 12.6 as supplemented with additional information included in this notice, and shall be processed in accordance with FAR Part 13 – Simplified Acquisition Procedures. This announcement constitutes the only solicitation, and a separate written solicitation will not be issued. This solicitation, 75N91024Q00086, is issued as a Request for Quote (RFQ) and includes all applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2024-05 (05/22/2024).
The North American Industry Classification System (NAICS) code is 334516 (Analytical Laboratory Instrument Manufacturing) with a size standard of 1,000 employees.
Only one (1) award will be made as a result of this RFQ. This requirement will be awarded as a firm fixed price purchase order.
Files
| File | Type | Posted |
|---|---|---|
| 75N91024Q00086_ComSynopSolicitation.pdf | ||
| 75N91024Q00086_Statement of Need.pdf | ||
| Attachment_52.212-3(MAY2024)_FullText.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| SOURCES SOUGHT NOTICE: Procurement of one (1) Brand Name or Equal Illumina NextSeq 550 Dx Sequencing System | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| DNA Sequencing Service | Office of Logisitics and Acquisition Operations | No set-aside | |
| Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000 | Naval Supply Systems Command | No set-aside | |
| RNA sequencing and whole genome sequencing services | Office of Logisitics and Acquisition Operations | No set-aside | |
| Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000 | Naval Supply Systems Command | No set-aside | |
| NCSS - Bioruptor Pico Sonication Device | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity